Abeona Therapeutics Inc.
ABEO· Nasdaq
Released May 11, 2023, before the open
10-Q filed May 11, 2023, 41 days after period end · 0001493152-23-016278
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | — | $346.00K | — | — |
| Net Income | -$9.11M | -$22.04M | -$16.00M | -$48.16M |
| EPS Diluted |
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR
| -$0.54 |
| — |
| -$0.17 |
| -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.